Myriad Genetics · 2 days ago
Product Mgr III Technology
United States
Full-time
Remote
Mid, Senior Level
4+ years expMyriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being. They are seeking a Senior Technical Product Manager to drive the EMR product strategy, manage product backlogs, and collaborate with engineering and business teams to enhance EMR features and performance.
BiotechnologyPharmaceuticalPrecision Medicine
No H1B
U.S. Citizen Only
Responsibilities
Own and prioritize product backlog; ensure requirements are clear and actionable
Lead strategy, requirements gathering, and release planning for assigned areas
Guide Agile ceremonies (planning, refinement, demos); resolve blockers and manage dependencies
Develop multi-release plans and coordinate scalable launches
Demonstrated ability to leverage AI tools and techniques to enhance day-to-day product management activities
Integrate EMR data and services into product strategy, ensuring seamless data flow between order capture, processing, fulfillment, and reporting systems
Collaborate with engineering and business teams to define requirements for EMR features, including order lifecycle management, exception handling, and data reconciliation
Monitor and optimize the performance of EMR services, focusing on data accuracy, transaction speed, and system reliability
Ensure compliance with regulatory and internal standards for EMR data security and privacy
Leverage analytics to identify trends and opportunities in EMR data, driving enhancements to user experience and operational efficiency
Qualification
Required
4+ years in product management or technical product owner roles
Strong technical background (Salesforce, Looker, custom software, cloud, web)
Experience with Agile tools (Jira, Azure DevOps)
Excellent communication and analytical skills
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase